newsfilter
← Latest News
Business Wire·

Humanigen and Cenexi Announce Collaboration to Manufacture Lenzilumab in France

Cenexi to Become Preferred Drug Product Supplier for France and the European Union Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine